Dupilumab for bullous pemphigoid induced by immune checkpoint inhibitors.

Authors: Ian Nykaza, Stephen W. Dusza, Gopa Iyer, Alina Markova

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e24110

Source: Full article

Abstract

e24110